|
|
|
Vtv Theraptcs Cl A 
|
2.53 0.16 (0.07%) |
02-24 15:34 |
Open: |
2.41 |
Pre close: |
2.37 |
Target:
|
3.45
|
High: |
2.62 |
Low: |
2.4 |
Resistance:
|
2.96
3.59
|
Volume: |
812,264 |
Market Cap: |
196M |
Support:
|
1.93
1.61
|
|
|
|
Technical Analysis |
Moving Averages |
MA(5):
|
2.62
 |
MACD |
MACD(12,26):
|
0.11  |
MA(20): |
2.52  |
Signal(12,26,9): |
0.13  |
MA(100): |
2.07  |
Stochastic Oscillator |
%K(14,3):
|
31.02  |
MA(250): |
2.22  |
%D(3): |
38.60  |
Average Volume(K) |
3-Month: |
526446
|
52-Week |
High:
|
4.75 |
10-Days: |
272616 |
Low: |
1.44 |
RSI |
RSI(14):
|
52.53  |
Change(%): |
-32.0 |
Financials, Statistics and Valuation |
EPS |
-0.334 |
Return on Equity (ttm) |
0.0 |
Shares Out. (M) |
54.55 |
EPS Est. Current Year |
-1.060 |
Return on Assets (ttm) |
-155.2 |
Shares Float (M) |
15.33 |
EPS Est. Next Year |
-2.250 |
PEG Ratio |
0.00 |
% Held by Insiders |
72.38 |
EPS Est. Next Quarter |
0.190 |
Qtrly Rev. Growth |
-12.5 |
% Held by Institutions |
8.01 |
Forward EPS |
-0.690 |
Gross Profit (p.s.) |
-0.227 |
Shares Short (K) |
2930 |
Book Value (p.s.) |
-1.040 |
EBITDA (p.s.) |
-0.366 |
P/E |
-7.63 |
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
-2.45 |
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-21.66 |
P/S |
6322.84 |
Operating Margin |
-91227.27 |
Levered Free Cash Flow
(M) |
-13.10 |
P/CF |
-6.42 |
|
|
|
|
|